Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Walgreens pays $269.2 million to settle U.S. civil fraud lawsuits

      Walgreens pays $269.2 million to settle U.S. civil fraud lawsuits

      Farhat Nasim25 Jan 2019 9:00 AM IST
      Walgreens will also pay $60 million to resolve claims it overcharged Medicaid from 2008 to 2017 by failing to disclose and charge the discount drug...
      Johnson and Johnson settles case in U.S for $120 million

      Johnson and Johnson settles case in U.S for $120 million

      Farhat Nasim24 Jan 2019 10:55 AM IST
      The states claimed Johnson and Johnson made misleading claims about the longevity of its metal-on-metal hip implants, with patients frequently having...
      Pricing of Pharma Products: Dr VK Paul led Standing Committee constituted to recommend prices to NPPA

      Pricing of Pharma Products: Dr VK Paul led Standing Committee constituted to recommend prices to NPPA

      Farhat Nasim23 Jan 2019 10:20 AM IST
      New Delhi: The government recently came up with an order which is likely to clip the powers of drug pricing regulator, National Pharmaceutical Pricing...
      Acceptance of eIFU for Medical Device a welcome move: MTaI

      Acceptance of eIFU for Medical Device a welcome move: MTaI

      Farhat Nasim23 Jan 2019 9:15 AM IST
      "The acceptance of eIFU for Medical Device and Equipment puts India's regulatory specifications in line with the practices of some of the advanced...
      Samsung Bioepis biosimilar to Roche Herceptin wins FDA nod

      Samsung Bioepis biosimilar to Roche Herceptin wins FDA nod

      Farhat Nasim23 Jan 2019 9:00 AM IST
      Herceptin, which generated sales of 7.01 billion Swiss francs in 2017, is one of the world’s most successful antibody drugs and has been a mainstay of...
      Sun Pharma takes steps to ease governance concerns

      Sun Pharma takes steps to ease governance concerns

      Farhat Nasim22 Jan 2019 5:19 PM IST
      Sun Pharma said on Tuesday it replaced Aditya Medisales with its wholly owned unit as the new distributor for its domestic formulations business. It...
      Zydus gets tentative USFDA nod to generic Esomeprazole Magnesium delayed release capsules

      Zydus gets tentative USFDA nod to generic Esomeprazole Magnesium delayed release capsules

      Farhat Nasim22 Jan 2019 9:15 AM IST
      Esomeprazole Magnesium reduces the amount of acid secreted by the stomach. The drug is used for the treatment of symptoms of gastroesophageal reflux...
      Glaxo Smith Kline Chairman Philip Hampton to step down

      Glaxo Smith Kline Chairman Philip Hampton to step down

      Farhat Nasim22 Jan 2019 9:00 AM IST
      "Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to...
      Why is Fortis buying the Assets of Singapore listed Trust: Report

      Why is Fortis buying the Assets of Singapore listed Trust: Report

      Farhat Nasim21 Jan 2019 3:44 PM IST
      These hospitals and clinics operated by RHT Health subsidiaries International Hospital Ltd, Fortis Health Management Ltd, Fortis Hospital Ltd, Escorts...
      Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

      Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

      Farhat Nasim21 Jan 2019 2:13 PM IST
      "Our idea is to focus only on tertiary care in cities and we are exploring new facilities in Mumbai, Pune and in Thiruvananthapuram, where we have...
      Wockhardt gets USFDA nod for generic Imatinib Mesylate tablets

      Wockhardt gets USFDA nod for generic Imatinib Mesylate tablets

      Farhat Nasim21 Jan 2019 12:58 PM IST
      Wockhardt's Imatinib Mesylate tablets are a generic version of Gleevec, marketed in the USA and other countries by Novartis.Mumbai: Drug firm...
      Series of Recall: Lupin, Sun pharma, Glenmark recall products in US

      Series of Recall: Lupin, Sun pharma, Glenmark recall products in US

      Farhat Nasim21 Jan 2019 11:09 AM IST
      The ongoing voluntary nationwide recall has been classified as Class-I and Class-II recall.New Delhi: Indian drug majors Lupin, Sun Pharma and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok